| 國立成功大學 |
2024-12 |
Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics
|
Lee;Kuo-Ting;Chen;Dao-Peng;Loh;Zhu-Jun;Chung;Wei-Pang;Wang;Chih-Yang;Chen;Pai-Sheng;Cheung;Antonio, Chun Hei;Chang;Chih-Peng;Hsu;Hui-Ping |
| 國立成功大學 |
2024-12 |
Sacituzumab govitecan in HR+HER2- metastatic breast cancer: the randomized phase 3 EVER-132-002 trial
|
Xu;Binghe;Wang;Shusen;Yan;Min;Sohn;Joohyuk;Li;Wei;Tang;Jinhai;Wang;Xiaojia;Wang;Ying;Im;Seock-Ah;Jiang;Dongdong;Valdez;Theresa;Dasgupta;Anandaroop;Zhang;Yiran;Yan;Yilin;Komatsubara;Kimberly, M.;Chung;Wei-Pang;Ma;Fei;Dai;Ming-Shen |
| 國立成功大學 |
2024-09 |
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
|
Iwata;Hiroji;Xu;Binghe;Kim;Sung-Bae;Chung;Wei-Pang;Park;Hee, Yeon;Kim;Hwan, Min;Tseng;Ling-Ming;Chung;Chi-Feng;Huang;Chiun-Sheng;Kim;Hyun, Jee;Chiu;Yan, Joanne Wing;Yamashita;Toshinari;Li;Wei;Egorov;Anton;Nishijima;Soichiro;Nakatani;Shunsuke;Nishiyama;Yuji;Sugihara;Masahiro;Cortes;Javier;Im;Seock-Ah |
| 國立成功大學 |
2024-08-10 |
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
|
Lu;Yen-Shen;Mahidin;Mohd, Eznal Izwadi Bin;Azim;Hamdy;Eralp;Yesim;Yap;Sim, Yoon;Im;Seock-Ah;Rihani;Julie;Gokmen;Erhan;Bastawisy, El;Ahmed;Karadurmus;Nuri;Lim;Ni, Yueh;Lim;Sen, Chun;Duc;Thanh, Le;Chung;Wei-Pang;Babu;Govind, K.;Penkov;Konstantin;Bowles;James;Alfaro;Delgar, Teresa;Wu;Jiwen;Gao;Melissa;Slimane;Khemaies;Saghir, El;Nagi, S. |
| 國立成功大學 |
2024-05-2 |
A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer
|
Lin;Wen-Der;Chang;Chia-Hao;Pan;Jhih-Kai;Lin;Forn-Chia;Chen;Yu-Chia;Chen;Ya-Jyun;Wang;Po-Shun;Hong;Wei-Qiao;Chen;Sheng-Yuan;Lin;Cheng-Han;Kuo;Yao-Lung;Chung;Wei-Pang;Cheng;Hui-Chuan;Hsiao;Michael;Yang;Chia-Ning;Lu;Pei-Jung |
| 國立成功大學 |
2023-06-23 |
Concise nanotherapeutic modality for cancer involving graphene oxide dots in conjunction with ascorbic acid
|
Shih;Chun-Yan;Wang;Pei-Ting;Chung;Wei-Pang;Wang;Wen-Hsiu;Chiang;I-Ting;Su;Wu-Chou;Huang;Wei-Lun;Teng;Hsisheng |
| 國立成功大學 |
2023-05-24 |
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw
|
Fu;Pei-An;Shen;Chin-Yao;Yang;Shuen-Ru;Lee;Chun-Hui;Chen;Hui-Wen;Lai;Edward, Chia-Cheng;Chung;Wei-Pang |
| 國立成功大學 |
2023-01-24 |
Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients-role of trastuzumab in HER2+BC and platinum in TNBC
|
Chung;Wei-Pang;Yang;Chun-Ting;Yang;Shuen-Ru;Su;Ching-Yen;Su;Hsin-Wei;Liu;Shang-Yun;Ou;Huang-Tz |
| 國立成功大學 |
2022-05 |
Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study
|
Shen;Chin-Yao;Au;Philip, Chun-Ming;Baek;Yeon-Hee;Cheung;Ching-Lung;Chung;Wei-Pang;Kim;Hwan, Ju;Kleinman;Nora, J.;Lam;Tai-Chung;Liao;Tzu-Chi;Lin;Tzu-Chieh;Shin;Ju-Young;Sing;Chor-Wing;Wong;Kei, Ian Chi;Lai;Edward, Chia-Cheng |
| 國立成功大學 |
2022-03 |
Real-time exercise reduces impaired cardiac function in breast cancer patients undergoing chemotherapy: A randomized controlled trial
|
Chung;Wei-Pang;Yang;Hsin-Lun;Hsu;Ya-Ting;Hung;Ching-Hsia;Liu;Ping-Yen;Liu;Yen-Wen;Chan;Shih-Hung;Tsai;Kun-Ling |
